Germany’s health authorities have warned young Germans not to receive the Moderna COVID-19 shot because they are concerned about rare heart inflammation.

The German Standing Committee on Vaccination (STIKO) said on Wednesday that people under age 30 who receive the Moderna jab are at an increased risk of developing myocarditis, and instead recommend opting for the Pfizer-BioNTech vaccine.

In Germany, the same advice was given to women who are pregnant.

Data from the Paul Ehrlich Institute (PEI), a German medical regulator body, shows the increased risk of heart inflammation is more than doubled among Moderna recipients.

Germany has become the seventh European country to adopt this kind of action, citing concerns over the side effects on young people.

Germany's advisory committee has recommended people under age 30 not get the Moderna COVID-19 vaccine (pictured), and instead opt for the Pfizer jab. Six other European nations have taken similar action in recent weeks

Germany’s advisory panel has advised that people younger than 30 years old not receive the Moderna COVID-19 vaccination (pictured) and to opt instead for the Pfizer jab. Similar actions have been taken by six European countries in the past weeks

Concerns about the Moderna vaccine causing myocarditis, and particularly in young males, have been raised worldwide in recent weeks. Pictured: A boy in Kiel, Germany, received a shot of a COVID-19 vaccine on August 19, 2021

Recent weeks have seen concerns raised about Moderna’s potential for myocarditis in young males. Pictured: On August 19, 2021, a boy from Kiel in Germany received an injection of the COVID-19 vaccine.

According to the PEI, heart inflammation was found in 11.71 percent of 100,000 men who received the Moderna jab.

Comparison: After receiving the Pfizer vaccination, only 4.81 of 100,000 men develop inflammation of their hearts.

STIKO’s recommendation isn’t binding – anyone can get the Moderna vaccine if they wish – but it has enough weight to discourage younger people from getting the shot. 

European countries have begun to doubt the Moderna jab’s safety for younger generations. 

Swedish officials discovered that the shot increases your risk of experiencing heart inflammation.

Responding, the government suspended all use of the shot to anyone born after 1990.

Officials in Sweden have not published the data, however they note that the Moderna shot has a very low risk of heart disease.

This Swedish decision set the stage for a chain of events across Scandinavia. 

Denmark quickly followed Sweden’s lead and stopped giving the jab to anybody under 18 years of age.

Finland came next with Finnish health officials deciding that the Moderna vaccine would not be offered to anyone under the age 30.

Iceland was the first to take the drastic step of suspending the Moderna COVID-19 vaccination in its small, island country.

French and Norweigan officials reviewed the data and decided that the Pfizer vaccine should be given to younger patients.

The countries, like Germany, did not stop using the jab but rather made a recommendation.

Last month, a Moderna spokesperson addressed the concerns about the vaccine restrictions in an email to Reuters.  

They wrote that these are often mild cases, and people tend to heal quickly after standard treatment and rest.

“Contagious COVID-19 increases the risk of myocarditis. It is best to get vaccinated.

American health professionals have recognized that myocarditis is a side effect of vaccines for many years. 

In June, the Centers for Disease Control and Prevention (CDC) issued a warning that young males were at an increased risk of myocarditis after receiving the vaccine.

A CDC advisory panel was presented with data about last month’s risk of Moderna vaccination causing inflammation in the heart.

Males under the age of 29 who receive the Pfizer (right) or Moderna (left) vaccine are at an increased risk of developing myocarditis after the second dose

Men under 29 years old who have received the Moderna or Pfizer vaccines are more likely to develop myocarditis.

Females do not share the same risk of developing heart inflammation as males do, even among the younger age groups

Even among younger generations, females are not at the same risk as men for developing heart inflammation. 

Researchers found that in both males and females, the risk of myocarditis is higher in people that receive the Moderna vaccine than the Pfizer. There are approximately 13.3 excess cases of heart inflammation per every one million shots of the Moderna vaccine than there are of the Pfizer shot

Research has shown that the Moderna vaccine is more effective than Pfizer in preventing myocarditis in males as well as females. For every million Moderna shots, there is an average of 13.3 cases of inflammation of the heart. This compares to the Pfizer shot.

This presentation revealed that men were more likely than women to get the condition. The risk was highest for those between the ages of 18-24 and 25 to 29, while the risk is also higher for the group between the ages of 25 to 29.

This is the dose that causes most cases of the disease.

However, the risk of developing myocarditis after 30 years old is low.

The U.S. Food and Drug Administration has not withdrawn its approval of Moderna because the risk of myocarditis from this jab is still lower than from Covid. 

This vaccine was administered more than 165 million times in America, making it the most popular of all three jabs. 

Kaiser Permanente Southern California conducted a study that found myocarditis in seven percent of those who received a COVID-19 two-shot vaccine.

This same study also found that heart inflammation is common in 47.5 percent of Covid patients.

People who receive the Covid vaccine are seven times as likely to develop heart inflamation after the second dose of the jab when compared to the first, finds a recent study by KPSC. Those who are unvaccinated are significantly more likely to develop myocarditis, however

According to a KPSC-recent study, people who get the Covid vaccine have seven times the risk of developing heart disease after receiving the second dose. However, those who have not been vaccinated for myocarditis are more likely than others to get it.

Myocarditis can often be treated by itself but it is still dangerous.

Patients suffering from heart inflammation often experience fatigue, chest pain and shortness of breath.

Inflamed hearts can increase the risk of heart attack, stroke and heart failure.

An inflamed heart may also cause sudden cardiac arrest and even death if you attempt to do strenuous activity.